NCT05950633

Brief Summary

This is a study evaluating a novel active recovery program in the immediate postoperative period following pelvic reconstructive surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 18, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

August 7, 2025

Status Verified

March 1, 2025

Enrollment Period

1.7 years

First QC Date

July 11, 2023

Last Update Submit

August 1, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in the Pelvic Floor Distress Inventory-20 (PFDI-20)

    The change in the Pelvic Floor Distress Inventory-20 (PFDI-20) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how much symptoms bother them from 0 (not at all) to 4 (quite a bit)

    Baseline to 12 weeks post-surgery

  • Change in the Short Form Health Survey (SF-36)

    The change in the Short Form Health Survey (SF-36) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their overall health. Scores can range from 0 to 100

    Baseline to 12 weeks

  • Change in the Patient Health Questionnaire (PHQ-9)

    The change in the Patient Health Questionnaire (PHQ-9) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how frequently problems have bothered them from 0 (not at all) to 4 (nearly every day)

    Baseline to 12 weeks post-surgery

  • Change in the Patient Global Impression of Improvement (PGI-I)

    The change in the Patient Global Impressions of Improvement (PGI-I) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their symptoms from 1 (very much better) to 7 (very much worse)

    Baseline to 12 weeks post-surgery

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

Participants will receive standard postoperative instructions only

Other: Standard of Care

Active Recovery

ACTIVE COMPARATOR

Participants will receive active recovery instructions with specific walking goals, abdominal strengthening exercises, and pelvic floor exercises

Other: Active Recovery

Interventions

Participants will receive standard of care postoperative instructions

Standard of Care

Participants will receive instructions to increase their fitness to walking at least 30 minutes a day for 5 days a week following surgery and abdominal and pelvic floor exercises will focus on abdominal wall strengthening and abdominal pressure management, urinary urgency and retention, bowel and constipation management

Active Recovery

Eligibility Criteria

Age18 Years - 89 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18 and 89
  • Undergoing minimally invasive apical prolapse reconstructive procedure at OHSU. This includes laparoscopic and robotic-assisted sacrocolpopexy, laparoscopic and vaginal uterosacral ligament suspension, and vaginal sacrospinous ligament fixation. We will include patients undergoing concomitant procedures such as hysterectomy and incontinence procedures.
  • Have access to reliable email for communication and questionnaires.

You may not qualify if:

  • Unable to consent
  • Unable to read and complete questionnaires in English
  • Unable to sustain 30 minutes of moderate walking/activity at baseline (self-reported)
  • Use a mobility assistance device such as a walker/cane at baseline
  • Balance or stability problems
  • Patients on chronic opioids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OHSU

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Pelvic Floor Disorders

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Sara Cichowski, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 11, 2023

First Posted

July 18, 2023

Study Start

September 1, 2023

Primary Completion

May 31, 2025

Study Completion

July 31, 2025

Last Updated

August 7, 2025

Record last verified: 2025-03

Locations